Erratum: Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects (Annals of the Rheumatic Diseases (2007) 66, (249-252))

F. Iannone, F. Trotta, C. Monteccuco, R. Giacomelli, M. Galeazzi, M. Matucci-Cerinic

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)847
Number of pages1
JournalAnnals of the Rheumatic Diseases
Issue number6
Publication statusPublished - Jun 2007

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this